Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangbai Liniment is a Traditional Chinese Medicine (TCM) topical preparation primarily derived from the bark of *Phellodendron amurense* (Huangbai). It is widely utilized in clinical practice in China for its potent anti-inflammatory, antibacterial, and wound-healing properties. The therapeutic efficacy of the liniment is largely attributed to its high content of alkaloids, most notably berberine, which exhibits broad-spectrum antimicrobial activity and modulates inflammatory signaling pathways. In clinical settings, Huangbai Liniment is often used for the management of skin infections, abdominal abscesses, and post-surgical wound recovery. Clinical trials, such as ChiCTR2200056082, have evaluated its effectiveness in treating abdominal abscesses by monitoring infection control, immune function markers, and inflammatory biomarkers, often comparing it to standard antibiotic treatments like gentamicin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangbai Liniment.